Cargando…

The biomarkers of immune dysregulation and inflammation response in Parkinson disease

Parkinson’s disease (PD) is referring to the multi-systemic α-synucleinopathy with Lewy bodies deposited in midbrain. In ageing, the environmental and genetic factors work together and overactive major histocompatibility complex pathway to regulate immune reactions in central nerve system which resu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Li, Mo, Mingshu, Li, Guangning, Cen, Luan, Wei, Lei, Xiao, Yousheng, Chen, Xiang, Li, Shaomin, Yang, Xinling, Qu, Shaogang, Xu, Pingyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5002148/ https://www.ncbi.nlm.nih.gov/pubmed/27570618 http://dx.doi.org/10.1186/s40035-016-0063-3

Ejemplares similares

Enhancing Beta-Catenin Activity via GSK3beta Inhibition Protects PC12 Cells against Rotenone Toxicity through Nurr1 Induction
por: Zhang, Limin, et al.
Publicado: (2016)

MicroRNA expressing profiles in A53T mutant alpha-synuclein transgenic mice and Parkinsonian
por: Mo, Mingshu, et al.
Publicado: (2016)

Rapamycin upregulates glutamate transporter and IL-6 expression in astrocytes in a mouse model of Parkinson's disease
por: Zhang, Yunlong, et al.
Publicado: (2017)

Recent Advance in the Relationship between Excitatory Amino Acid Transporters and Parkinson's Disease
por: Zhang, Yunlong, et al.
Publicado: (2016)

Bone-Derived Factors as Potential Biomarkers for Parkinson’s Disease
por: Lin, Yuwan, et al.
Publicado: (2021)

CHCHD2 maintains mitochondrial contact site and cristae organizing system stability and protects against mitochondrial dysfunction in an experimental model of Parkinson's disease
por: Lu, Lin, et al.
Publicado: (2022)

Parkinson’s disease in a patient with GBA and LRRK2 covariants after acute hypoxic insult: a case report
por: Tang, Yuting, et al.
Publicado: (2023)

Wnt1 Promotes EAAT2 Expression and Mediates the Protective Effects of Astrocytes on Dopaminergic Cells in Parkinson's Disease
por: Wei, Lei, et al.
Publicado: (2019)

Editorial: Biomarkers and Pathogenesis of Alpha-Synuclein in Parkinson's Disease
por: Li, Puyu, et al.
Publicado: (2021)

Soluble Aβ Oligomers Formed Channels Leading to Calcium Dysregulation
por: Li, Shaomin
Publicado: (2023)

Identification of Dysregulated Mechanisms and Potential Biomarkers in Ischemic Stroke Onset
por: Feng, Bing, et al.
Publicado: (2021)

Lipid Metabolism Disorder in Cerebrospinal Fluid Related to Parkinson’s Disease
por: Qiu, Jiewen, et al.
Publicado: (2023)

Acupuncture Modulates the Cerebello-Thalamo-Cortical Circuit and Cognitive Brain Regions in Patients of Parkinson's Disease With Tremor
por: Li, Zhe, et al.
Publicado: (2018)

Inflammation, Immune Senescence, and Dysregulated Immune Regulation in the Elderly
por: Shive, Carey, et al.
Publicado: (2022)

A case of congenital afibrinogenemia with multiple thrombotic and hemorrhagic disorders
por: Wei, Lijian, et al.
Publicado: (2022)

Reduced regional activity and functional connectivity within sensorimotor network in Parkinson’s patients with restless legs syndrome
por: Li, Zhe, et al.
Publicado: (2019)

The Potential Circular RNAs Biomarker Panel and Regulatory Networks of Parkinson’s Disease
por: Xiao, Yousheng, et al.
Publicado: (2022)

Lipid profiles in the cerebrospinal fluid of rats with 6-hydroxydopamine-induced lesions as a model of Parkinson’s disease
por: Qiu, Jiewen, et al.
Publicado: (2023)

Central Administration of 5Z-7-Oxozeaenol Protects Experimental Autoimmune Encephalomyelitis Mice by Inhibiting Microglia Activation
por: Lu, Lingli, et al.
Publicado: (2017)

Inflammation biomarker discovery in Parkinson’s disease and atypical parkinsonisms
por: Santaella, Anna, et al.
Publicado: (2020)

The dysregulation of immune cells induced by uric acid: mechanisms of inflammation associated with hyperuricemia and its complications
por: Li, Delun, et al.
Publicado: (2023)

Inflammation and Neuro-Immune Dysregulations in Autism Spectrum Disorders
por: Siniscalco, Dario, et al.
Publicado: (2018)

The extracellular microenvironment in immune dysregulation and inflammation in retinal disorders
por: Biasella, Fabiola, et al.
Publicado: (2023)

Molecular Mechanisms of Glutamate Toxicity in Parkinson’s Disease
por: Wang, Ji, et al.
Publicado: (2020)

Dysregulation of the Adaptive Immune System in Patients With Early-Stage Parkinson Disease
por: Yan, Zhaoqi, et al.
Publicado: (2021)

Soluble Triggering Receptor Expressed on Myeloid Cells 2 From Cerebrospinal Fluid in Sleep Disorders Related to Parkinson’s Disease
por: Mo, Mingshu, et al.
Publicado: (2021)

Circadian dysregulation in Parkinson's disease
por: Videnovic, Aleksandar, et al.
Publicado: (2016)

Predictors of dopamine dysregulation syndrome in patients with early Parkinson’s disease
por: Liang, Keke, et al.
Publicado: (2023)

Dysregulated gene-associated biomarkers for Alzheimer’s disease and aging
por: Li, Min, et al.
Publicado: (2021)

Single-cell analysis reveals dysregulated inflammatory response in peripheral blood immunity in patients with acute respiratory distress syndrome
por: Mo, Jingjia, et al.
Publicado: (2023)

Functional validation of a human GLUD2 variant in a murine model of Parkinson’s disease
por: Zhang, Wenlong, et al.
Publicado: (2020)

Association Analysis of Proteasome Subunits and Transporter Associated with Antigen Processing on Chinese Patients with Parkinson's Disease
por: Mo, Ming-Shu, et al.
Publicado: (2016)

Intestinal Inflammation and Parkinson’s Disease
por: Li, Yu, et al.
Publicado: (2021)

Inflammation and immune dysfunction in Parkinson disease
por: Tansey, Malú Gámez, et al.
Publicado: (2022)

Plasma α‐synuclein and phosphorylated tau 181 as a diagnostic biomarker panel for de novo Parkinson’s disease
por: Ren, Jingru, et al.
Publicado: (2022)

Association of LAG3 genetic variation with an increased risk of PD in Chinese female population
por: Guo, Wenyuan, et al.
Publicado: (2019)

The role of the microbiota-gut-brain axis and intestinal microbiome dysregulation in Parkinson’s disease
por: Li, Qing, et al.
Publicado: (2023)

Gain-of-function variants in SYK cause immune dysregulation and systemic inflammation in humans and mice
por: Wang, Lin, et al.
Publicado: (2021)

Parkinson's disease peripheral immune biomarker profile: a multicentre, cross-sectional and longitudinal study
por: Li, Yuanyuan, et al.
Publicado: (2022)

LMO3 downregulation in PCa: A prospective biomarker associated with immune infiltration
por: Xu, Wenchao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4cvljrr0934l6kmt3qh68u6jdk